Arvinas (ARVN) Non-Current Assets (2017 - 2026)

Arvinas (ARVN) recorded quarterly Non-Current Assets of $16.8 million in Q1 2026, down 2.33% quarter-over-quarter from $17.2 million in Q4 2025, and down 21.5% on a YoY basis from $21.4 million in Q1 2025.

Arvinas (ARVN) Non-Current Assets (2017 - 2026) Analysis & Trends

Arvinas' Non-Current Assets history runs 10 years deep, the most recent figure standing at $16.8 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 21.5% year-over-year to $16.8 million; the TTM figure through Mar 2026 stood at $71.8 million (down 16.51% YoY), while the FY2025 annual figure was $17.2 million, down 28.63% from the prior year.
  • Non-Current Assets was $16.8 million for Q1 2026 at Arvinas, down from $17.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $31.3 million in Q1 2022 to a low of $16.8 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $23.8 million across 5 years, with a median of $24.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 87.81% in 2022, then slumped 30.43% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $28.6 million in 2022, then fell by 14.69% to $24.4 million in 2023, then dropped by 1.23% to $24.1 million in 2024, then retreated by 28.63% to $17.2 million in 2025, then dropped by 2.33% to $16.8 million in 2026.
  • The last three Non-Current Assets figures came in at $16.8 million (Q1 2026), $17.2 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 16.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.80 Mn
Dec 31, 2025 17.20 Mn
Sep 30, 2025 18.00 Mn
Jun 30, 2025 19.80 Mn
Mar 31, 2025 21.40 Mn
Dec 31, 2024 24.10 Mn
Sep 30, 2024 17.60 Mn
Jun 30, 2024 22.90 Mn
Mar 31, 2024 22.30 Mn
Dec 31, 2023 24.40 Mn
Sep 30, 2023 25.30 Mn
Jun 30, 2023 26.80 Mn
Mar 31, 2023 27.60 Mn
Dec 31, 2022 28.60 Mn
Sep 30, 2022 30.10 Mn
Jun 30, 2022 30.60 Mn
Mar 31, 2022 31.30 Mn
Dec 31, 2021 29.10 Mn
Sep 30, 2021 28.71 Mn
Jun 30, 2021 16.29 Mn